Eton Pharmaceutical

Şirket Açıklaması

Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the FDA’s 505(b)(2) regulatory pathway. Our business model is to develop proprietary innovative products that fulfill an unmet patient need. We have established a diversified pipeline of eight product candidates in various stages of development. Our corporate strategy is to pursue what we perceive to be low-risk 505(b)(2) candidates where existing published literature, historical clinical trials, or physician usage has established safety or efficacy of the molecule, thereby reducing the incremental clinical burden required for us to bring the product to patients. We intend to focus on product candidates that are currently unapproved or product candidates that we believe will offer innovative and proprietary functional advantages to currently available alternatives.

Şirket Genel Bakışı

Şirket AdıEton Pharmaceutical
Sektörİlaç

IPO Verileri

Tarih8.11.2018
Fiyat$ 6
Hisse Senedi Arzı3.600.000
İşlem Hacmi$ 21.600.000
Şirket SembolüETON
BorsaNASDAQ (NASDAQ)
E-BÜLTEN ABONELİĞİ
Websitemizdeki güncellemeler ve son İPO duyuruları ile ilgili haberdar olmak için e-mail listemize abone olun.
BİZİ TAKİP EDİN
Bizi sosyal medyada takip etmeyi unutmayın